2026年，短剧强势杀入春节档，头部短剧《十八岁太奶奶驾到，重整家族荣耀第四部》，2月18日上线一周后红果热度值破1亿、观看量破10 亿。 事实上，看重短剧庞大的用户基数和流量，珀莱雅（603605.SH）、上美股份（02145.HK）、丸美生物（603983.SH）、贝泰妮（300957.SZ） 等美妆公司已纷纷下场，在霸总、甜宠、复仇等各类型短剧中，悄然植入自家产品。 据不完全统计，上美股份于2023年~2024年推出短剧近30部，打响了韩束品牌"红蛮腰"系列礼盒；A股美妆龙头珀莱雅，也通过《全职主夫培 养计划》《觉醒吧恋爱脑》等短剧，主推"红宝石"套装和"双抗"系列大单品；贝泰妮也在短剧《霸道总裁俏村花青刺果之恋》中植入薇诺娜品 牌舒敏特护霜；而在短剧《双A夫妇又美又飒》中，女主角的身份直接被设定为丸美集团的千金…… 随着众多玩家入局，美妆公司投资短剧，还是一门好生意吗？ | 2025年前三季度 | | 营收占比 2025年前三季度 | | 营收占比 2025年前三季度 | | --- | --- | --- | --- | --- | | 销售费用(亿元) | | · 研发费用(亿元) | | 营收( ...

2025年以来，中国美妆行业迎来一场久违的资本竞速赛。 林清轩、HBN、半亩花田、自然堂、植物医生等一众国货美妆品牌密集递交招股书，甚至是已经上市的老牌国货美妆品牌珀莱雅、丸美生物亦向 港交所发起冲刺。 表面上看这是国货美妆集体爆发的"高光时刻"。 但透过厚重的招股书与财报数据，却能嗅到一股强烈的行业焦虑：线上流量红利见顶，"买量换增长"的边际效益逐渐递减。 面对这一增长瓶颈，向实体零售要增量成为破局的共识。以HBN、半亩花田等为代表的新锐国货品牌正急于抢抓IPO的时间窗口，试图募资"弹 药"大举加码线下市场，通过在一二线核心商圈铺设直营专柜、快闪店与精品店，构建起更重的资产壁垒。 而在新锐势力"线下"的攻势面前，那些原本拥有庞大实体分销网络的老牌美妆巨头正面临更多挑战。 面对传统客流被分流的压力，老牌巨头们被迫走出渠道舒适区，加速在美团、京东秒送等"即时零售"新业态中寻找增量以图反击，试图用数字化 网络重新激活厚重的线下基本盘。 这种触达路径的根本性颠覆，让那些原本难以攻入核心商圈的新锐国货可以绕过巨头，在直播间的聚光灯下获得一条足以"弯道超车"的黄金赛 道。 正是在这一时期，国货美妆品牌纷纷崛起。 以HB ...

Summary of the Conference Call for Proya (珀莱雅) Company Overview - Proya is a cosmetics company that has experienced fluctuations in its valuation since its IPO in 2017, driven by net profit growth and a focus on blockbuster products during its initial years [2][4]. Key Points and Arguments Financial Performance - Since 2025, Proya has seen a significant slowdown in quarterly revenue growth, although the first quarter of 2025 exceeded profit expectations. Overall, the sustainability of this growth is questionable [3]. - The gross margin has shown a steady increase, while the net profit margin has remained relatively stable. However, the valuation has been on a downward trend since 2025, currently at historical lows [3][4]. Brand Performance - The main brand, Proya, experienced negative growth overall in 2025, with only the third quarter showing positive growth due to new product launches and a low base effect. In contrast, sub-brands such as of relax, 原色波塔, and 花知晓 performed exceptionally well, with of relax achieving a compound growth rate close to 150% [2][6]. Leadership and Strategic Concerns - There are concerns regarding the declining momentum of the main brand and risks associated with leadership changes. However, the new leadership team has successfully integrated over the past year, and the operational capabilities of the company have matured [7]. Product Innovation - Proya is actively pursuing product innovation in 2025, including upgrades to the dual-antioxidant series, which saw a 72% year-on-year increase within 10 days of launch, and a significant upgrade to the ruby series. A new ruby microbead essence is set to be launched, promoted through social media platforms like 小红书 [8]. Future Directions - The company plans to focus on key areas such as whitening, soothing, anti-aging, sun protection, and post-operative recovery. Additionally, Proya is investing in emerging brands like 花知晓 to expand its market presence and is exploring the home beauty device sector to tap into the broader water-light market [9][10]. Profit Forecast - Proya's net profit is projected to be approximately 1.58 billion yuan in 2025, maintaining slight growth, with an expected increase to 1.74 billion yuan in 2026, representing a year-on-year growth of around 10%. The current price-to-earnings ratio is 16 times, indicating a relatively cheap valuation compared to its quality [5][11]. Additional Important Insights - The company’s ability to regain valuation hinges on the recovery of its main brand's performance and stable growth across its business segments [4]. - Proya aims to establish itself as a benchmark for domestic brands and pursue international expansion to achieve valuation premiums [5][11].

Core Insights - The company achieved a revenue of 7.098 billion yuan in the first three quarters of 2025, reflecting a year-on-year growth of 1.89%, and a net profit of 1.026 billion yuan, up 2.65% year-on-year, indicating a rational return to growth amidst a challenging consumer environment [1] - The improvement in gross margin to 73.69% from 70.07% and a net profit margin of 14.86% highlights the company's position as a leading player in the domestic beauty market [1] - The company is transitioning from a focus on rapid expansion to prioritizing quality and sustainability, as evidenced by a significant increase in operating cash flow by 196.65% year-on-year to 1.198 billion yuan [1] Financial Performance - Revenue for the first three quarters of 2025 reached 7.098 billion yuan, a 1.89% increase year-on-year [1] - Net profit was reported at 1.026 billion yuan, reflecting a 2.65% year-on-year growth [1] - Operating cash flow significantly improved to 1.198 billion yuan, marking a 196.65% increase year-on-year [1] Brand Strategy - The company is shifting its growth logic from reliance on single blockbuster products to a multi-brand collaboration approach, focusing on structural growth rather than just volume [2][3] - The main brand continues to serve as a core anchor for profit and reputation, with successful product lines validating the closed-loop model of "scientific ingredients - product efficacy - market conversion" [3] - The company is replicating its successful product validation model across other brands, enhancing their market presence and operational capabilities [4] Research and Development - The company maintains a stable R&D expense ratio of 2%, investing 142 million yuan in R&D in the first three quarters of 2025, which is crucial for long-term sustainable growth [8] - Recent collaborations with universities for research projects indicate a shift towards a more integrated research ecosystem, enhancing the company's innovation capabilities [8][12] - The establishment of multiple R&D centers in China and Europe supports a comprehensive research framework, focusing on anti-aging mechanisms and sustainable ingredient development [12] Organizational Changes - Recent management changes signal a transition from founder-led to a more professional governance structure, emphasizing collaboration and system thinking [14][15] - The new management team, with diverse backgrounds, aims to enhance organizational resilience and internal collaboration, aligning with the company's long-term strategic goals [15] - The company is positioning itself as an "enabler" in the beauty industry through strategic investments, such as in the domestic makeup brand Huazhixiao, to connect with younger consumers [16][17] International Expansion - The submission of an H-share listing application to the Hong Kong Stock Exchange marks a significant step towards international capital market entry, enhancing the company's governance and transparency [17][18] - The company aims to leverage its international presence to strengthen its research and innovation capabilities, creating a cycle of "domestic R&D + international innovation" [17][18] - The focus on long-term value creation reflects a shift in corporate strategy from immediate gains to sustainable growth, positioning the company for future success in the global beauty market [18]

Core Viewpoint - Proya Cosmetics has officially submitted an IPO application to the Hong Kong Stock Exchange, aiming to become the largest domestic cosmetics group listed in both A and H shares [4][5]. Company History and Development - Proya was founded in 2003 by Hou Juncheng and his brother-in-law Fang Youyou in Hangzhou, overcoming challenges in a market dominated by international brands [6][7]. - The company initially struggled but began to gain traction around 2007 by associating itself with hydration and leveraging celebrity endorsements, leading to significant revenue growth [7]. - Proya achieved revenue of 1 billion RMB for the first time in 2008 and entered the top tier of domestic cosmetics brands by 2013 [7]. Financial Performance - In 2023, Proya reported revenue of 8.905 billion RMB, surpassing competitors like Shanghai Jahwa and Huaxi Biological, establishing itself as a leader in the domestic beauty market [7][9]. - The company is projected to reach 10.778 billion RMB in revenue for 2024, with net profits expected to grow from 1.230 billion RMB in 2022 to 1.585 billion RMB in 2024 [9][10]. - The first half of 2025 saw Proya generate 5.362 billion RMB in revenue, marking a 7.21% year-on-year increase, with net profit rising by 13.80% [9][10]. Management Transition - In September 2022, Hou Yamen, the son of founder Hou Juncheng, took over as CEO, marking a significant leadership change [9][11]. - The company has experienced several high-level executive departures since the transition, which has raised concerns about management stability [11]. Market Position and Competitive Landscape - Proya's market capitalization is currently around 29.2 billion RMB, but it has seen a decline of over 10% in stock price this year, resulting in a loss of approximately 4 billion RMB in market value [11]. - The company has a diverse brand portfolio, including Proya, Caitang, and Off&Relax, with several brands exceeding 500 million RMB in sales [11]. Industry Trends - There is a growing trend of domestic beauty brands pursuing IPOs, with several companies, including Lin Qingxuan and Zhenyan Biotechnology, also seeking to list [12][13]. - The beauty industry is witnessing a capital wave, with many companies aiming to attract international investment by meeting specific profit thresholds [15].

Core Insights - The company reported a revenue of 7.098 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 1.89% [1] - The net profit attributable to shareholders reached 1.026 billion yuan, with a year-on-year increase of 2.65% [1] - The gross profit margin improved to 73.69%, up 3.62 percentage points from 70.07% in the same period of 2024, while the net profit margin was 14.86% [1][7] Brand Performance - The flagship brand, Proya, has maintained a strong market position, leading the Tmall beauty category during the Double Eleven shopping festival [4] - Multiple brands under the company, including Off&Relax and others, are experiencing rapid growth and complementing each other in market coverage [2] Research and Development - The R&D expense ratio was stable at 2.00%, with R&D investment amounting to 142 million yuan, supporting the synergy between R&D and profitability [7] - The company has established a diverse R&D system, focusing on technological innovation, including a partnership with Sichuan University to research mitochondrial anti-aging [7] Strategic Outlook - The company has demonstrated resilience and strategic clarity through consistent revenue growth, improved profitability, and ongoing commitment to R&D and multi-brand strategies [8] - Future prospects include enhanced R&D innovation, digital capabilities, and accelerated globalization, positioning the company to continue leading the domestic beauty industry [8]

Core Insights - The company reported a revenue of 7.098 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 1.89%, with a net profit of 1.026 billion yuan, up 2.65% year-on-year [1] - The gross margin reached 73.69%, an increase of 3.62 percentage points from the same period in 2024, while the net margin was 14.86%, indicating an improvement in profitability quality [1] Revenue Growth Strategy - The growth is attributed to the company's multi-brand strategy, which emphasizes the core brand's stability and new brand growth, enhancing its market position in the skincare sector [2] - The flagship brand, Proya, has maintained its leading position in the market, particularly during the Double 11 shopping festival, where it ranked first in the Tmall beauty category for the first four hours of sales [4] Research and Development - The company maintained a stable R&D expense ratio of 2.00%, with R&D investments amounting to 142 million yuan, supporting product upgrades and enhancing profitability [5] - Recent collaborations and innovations in R&D, such as partnerships with Sichuan University and the release of a white paper on scalp microecology, have strengthened the company's competitive edge in the beauty industry [5]

Core Viewpoint - The 2025 CAME (China Aroma and Cosmetic Industry Annual Conference and Expo) held in Nanjing focused on "Technology, Brand, and Co-prosperity," showcasing over 500 brands and more than 1,000 new products, emphasizing the integration of government, industry, academia, research, and investment [2][5][38]. Group 1: Event Overview - The event featured high-quality, high-standard, and professional exhibitions, attracting leading beauty companies such as L'Oréal, Procter & Gamble, and Unilever, along with top raw material suppliers like BASF and DSM, creating an "all-star" lineup [5][10]. - CAME has evolved into a "core technology release conference" for domestic and international beauty brands and raw material companies, highlighting its significance in the industry [8][10]. Group 2: Technological Innovations - Numerous innovative technological achievements were showcased, with a strong emphasis on "Chinese-style innovation," including Proya's mitochondrial anti-aging technology and Shiseido's research on the hidden skincare benefits of fermented natto bacteria [10][11][17]. - Shanghai Jahwa introduced the industry's first non-invasive skin glycation quantification and imaging device, filling a gap in the cosmetic field [12]. Group 3: Industry Trends - The event highlighted a shift in the cosmetics industry from "scale expansion" to "value enhancement," with raw material innovation becoming a strategic pivot for this transformation [23][38]. - The demand for diverse consumer needs is pushing upstream supply chain companies to continuously innovate in technology research and scientific communication [23][26]. Group 4: Collaboration and Future Outlook - CAME serves as a bridge for collaboration among raw material suppliers, brands, distributors, and technology companies, accelerating technology transfer and commercial cooperation [34][37]. - The conference is viewed as a crucial opportunity for enhancing the global competitiveness of domestic brands, with a focus on high-quality innovation and development [38].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 5.36 billion yuan for H1 2025, representing a year-on-year growth of 7.2%, while the net profit attributable to shareholders was 800 million yuan, up 13.8% year-on-year. In Q2 alone, revenue was 3 billion yuan, with a year-on-year increase of 6.5%, and net profit of 410 million yuan, growing 2.4% year-on-year [2][4]. - The company plans to issue H shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and overseas business development, as well as enhance its overseas financing capabilities [2][4]. Financial Performance - In H1 2025, online direct sales, online distribution, and offline sales generated revenues of 3.91 billion, 1.2 billion, and 250 million yuan respectively, with year-on-year changes of 4.9%, 25.9%, and -21.5% [9]. - The main brand and sub-brands showed varied performance, with the main brand's revenue slightly declining by 0.1%, while sub-brands like OR and 原色波塔 saw significant growth of 103% and 80% respectively [9]. - The gross profit margin improved by 3.6 percentage points in H1 2025, attributed to cost reduction and efficiency improvements [9]. - The overall net profit margin increased by 0.9 percentage points to 14.9%, although Q2 saw a slight decline of 0.5 percentage points to 13.6% due to increased sales expenses during promotional periods [9]. Future Outlook - The company is expected to benefit from the ongoing expansion of its main brand and the continued strong performance of its sub-brands, which could contribute to incremental growth [9]. - EPS forecasts for 2025, 2026, and 2027 are projected to be 4.28, 5.05, and 5.77 yuan per share respectively [9].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [4][12]. Core Insights - The company achieved a revenue of 5.362 billion yuan in H1 2025, representing a year-on-year growth of 7.21%. The net profit attributable to shareholders was 799 million yuan, up 13.80% year-on-year [1]. - The skincare segment showed steady growth, with revenue of 4.199 billion yuan in H1 2025, a slight increase of 0.20% year-on-year, while the beauty makeup segment grew by 25.79% to 837 million yuan [2]. - The company plans to list in Hong Kong to further its international strategy [1]. Financial Performance - The gross margin for H1 2025 increased by 3.56 percentage points to 73.38%, while the net profit margin rose by 0.86 percentage points [3]. - The main brand, Proya, generated 3.979 billion yuan in revenue, a slight decline of 0.08% year-on-year, while the sub-brand Cai Tang saw a revenue increase of 21.11% to 705 million yuan [4]. - The company forecasts net profits of 1.8 billion yuan, 2.08 billion yuan, and 2.35 billion yuan for 2025, 2026, and 2027, respectively, with growth rates of 15.9%, 15.3%, and 13.2% [4][6]. Revenue Breakdown - In H1 2025, online sales accounted for 95.39% of total revenue, amounting to 5.109 billion yuan, while offline sales decreased by 21.49% to 247 million yuan [2]. - The revenue from the hair care segment surged by 131.25% to 320 million yuan, indicating strong performance in this category [2]. Future Projections - The company expects revenue growth rates of 10.3%, 7.8%, and 6.5% for the years 2025, 2026, and 2027, respectively [6][9]. - The projected earnings per share for 2025, 2026, and 2027 are 4.54 yuan, 5.24 yuan, and 5.93 yuan, respectively [6][9]. Brand Development - The main brand Proya continues to enhance its brand strength, while other brands are also making significant progress, with Off&Relax being the fastest-growing brand, achieving a revenue of 279 million yuan, up 102.52% year-on-year [4].